EricKoMD

Thoracic Cancer, Urologic Cancer

Dr. Ko is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Office
55 Lake Ave
Worcester, MA 01655
Phone+1 774-442-5551

Fax+1 774-442-5006

Icahn School of Medicine at Mount SinaiChief Residency, Radiation Oncology, 2012 - 2013
Icahn School of Medicine at Mount SinaiResidency, Radiation Oncology, 2009 - 2013
Christiana Care Health ServicesInternship, Transitional Year, 2008 - 2009
Jacobs School of Medicine and Biomedical Sciences at the University at BuffaloClass of 2008

RSNA Roentgen Resident/Fellow Research Award Radiological Society of North America, 2012
Predoctoral Fellowship Department of Defense, 2005
AACR-Aventis Oncology Scholar-in-Training American Association for Cancer Research, 2003
T32 Predoctoral Trainee National Institutes of Health/National Cancer Institute, 2002
Join now to see all

PubMed

Abstracts/Posters

Adjusted risk stratification for Gleason score (GS) 8 prostate cancer patients treated with trimodality therapy
Liu JT, Ko EC, Stone NN, Stock RG, ASTRO 2012, Boston, MA, USA
The potential impact of medications on biochemical control following definitive management of prostate cancer
Blacksburg SR, Ko EC, Stone NN, Stock RG, ASTRO 2012, Boston, MA, USA
Association of genetic factors with PSA response in prostate cancer patients receiving definitive radiotherapy
Ko E, Kerns SL, Stone NN, Stock RG, Ostrer H, Rosenstein BS, ASTRO 2012, Boston, MA, USA
Quality of life with adjuvant radiotherapy following transoral robotic surgery (TORS) for head and neck cancer
Carpenter TJ, Gupta V, Buckstein MH, Ko EC, Posner MR, Genden EM, ASTRO 2012, Boston, MA, USA
PSA nadir of <0.5ng/ml following brachytherapy for early stage prostate adenocarcinoma predicts for freedom from PSA failure and distant metastasis
Ko EC, Stone NN, Stock RG, ASTRO 2010, San Diego, CA, USA
Early PSA failure time following brachytherapy predicts for decreased prostate-specific and overall survival
Ko EC, Stone NN, Stock RG, ASTRO 2011, Miami Beach, FL, USA
Join now to see all